DrugPatentWatch Database Preview
Details for Patent: 6,713,446
Which drugs does patent 6,713,446 protect, and when does it expire?
Patent 6,713,446 protects VELCADE and is included in one NDA.
Protection for VELCADE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-three patent family members in twelve countries.
Summary for Patent: 6,713,446
| Title: | Formulation of boronic acid compounds |
| Abstract: | The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of the formula (1): ##STR1## in which Z.sup.1 and Z.sup.2 are moieties derived from sugar. The invention also provides methods for preparing such compounds. Lyophilizing a mixture comprising a boronic acid compound and a moiety derived from sugar produces a stable composition that readily releases the boronic acid compound upon reconstitution in aqueous media. |
| Inventor(s): | Gupta; Shanker Lal (Rockville, MD) |
| Assignee: | The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, DC) |
| Application Number: | 10/056,567 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,713,446 |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for Patent 6,713,446 |
|
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 6,713,446
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Millennium Pharms | VELCADE | bortezomib | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | 021602-001 | May 13, 2003 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
International Family Members for US Patent 6,713,446
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 501157 | ➤ Sign Up | |||
| Australia | 2002243646 | ➤ Sign Up | |||
| Canada | 2435124 | ➤ Sign Up | |||
| Canada | 2435146 | ➤ Sign Up | |||
| Cyprus | 1111488 | ➤ Sign Up | |||
| Cyprus | 1117484 | ➤ Sign Up | |||
| Germany | 60239384 | ➤ Sign Up | |||
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
